Please assess the completion status of the following clinical trial:

Trial Title: Below Knee DVT Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients over the age of 18 admitted to a trauma or general surgery service will be eligible~* Patients diagnosed with an isolated distal DVT~* Able to obtain informed consent~Exclusion Criteria:~* Patients with a previous diagnosis of hypercoagulability~* Patients on chronic anticoagulation~* Patients with a history of heparin induced thrombocytopenia~* Patients have preexisting contraindications to anticoagulation~* Patients in renal failure requiring adjusted enoxaparin dosing~* Pregnant patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Low Dose Enoxaparin (Type: ACTIVE_COMPARATOR): Subjects are randomized to receive or begin prophylactic dosing (30 mg BID) of enoxaparin for 6 weeks or until DVT resolution.
- High Dose Enoxaparin (Type: ACTIVE_COMPARATOR): Subjects are randomized to begin therapeutic dosing (1 mg/kg body weight BID) of enoxaparin for 6 weeks or until DVT resolution.

Based on this trial design, predict the completion outcome and termination type (if applicable).